Found: 3
Select item for more details and to access through your institution.
The effect of 5‐azacytidine treatment delays and dose reductions on the prognosis of patients with myelodysplastic syndrome: how to optimize treatment results and outcomes.
- Published in:
- British Journal of Haematology, 2021, v. 192, n. 6, p. 978, doi. 10.1111/bjh.17062
- By:
- Publication type:
- Article
The prognostic significance of macrocytosis in patients with myelodysplastic neoplasms.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 5, p. E119, doi. 10.1002/ajh.26886
- By:
- Publication type:
- Article
Characteristics of Long-Term Survival in Patients With Myelodysplastic Syndrome Treated With 5-Azacyditine: Results From the Hellenic 5-Azacytidine Registry.
- Published in:
- 2020
- By:
- Publication type:
- journal article